Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group. (Q50861786)
Jump to navigation
Jump to search
scientific article published in October 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group. |
scientific article published in October 1998 |
Statements
1 reference
Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group. (English)
1 reference
G D Demetri
1 reference
M Kris
1 reference
J Wade
1 reference
L Degos
1 reference
D Cella
1 reference
1 October 1998
1 reference
16
1 reference
3412-3425
1 reference
10
1 reference
Identifiers
1 reference